Keros Therapeutics, Inc. · NASDAQ:KROS

ADAR1 Capital Management, LLC reported a 0% stake in Keros Therapeutics, Inc. (Schedule 13D/A)

Event Oct 15, 2025 · Filed Oct 15, 2025

ADAR1 Capital Management, LLC reported a 0% stake in Keros Therapeutics, Inc., 0 shares, with active intent on Oct 15, 2025. Filed Oct 15, 2025 (Schedule 13D/A).

Stake
0%
Shares
0
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC0%0
ADAR1 Capital Management GP, LLC0%0
Daniel Schneeberger0%0

Source

View original at SEC

Related